203 related articles for article (PubMed ID: 32380408)
1. Mitochondrial-targeted ubiquinone alleviates concanavalin A-induced hepatitis via immune modulation.
Desta YT; Wu M; Bai L; Wu X; Xiong M; Weng X
Int Immunopharmacol; 2020 Jul; 84():106518. PubMed ID: 32380408
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid alleviates Con A-induced hepatitis and differentially regulates effector production in NKT cells.
Lee KA; Song YC; Kim GY; Choi G; Lee YS; Lee JM; Kang CY
Eur J Immunol; 2012 Jul; 42(7):1685-94. PubMed ID: 22585464
[TBL] [Abstract][Full Text] [Related]
3. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.
Fullerton AM; Roth RA; Ganey PE
Toxicol Sci; 2013 Nov; 136(1):72-85. PubMed ID: 23970800
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
Dashdorj A; Jyothi KR; Lim S; Jo A; Nguyen MN; Ha J; Yoon KS; Kim HJ; Park JH; Murphy MP; Kim SS
BMC Med; 2013 Aug; 11():178. PubMed ID: 23915129
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis.
Chacko BK; Srivastava A; Johnson MS; Benavides GA; Chang MJ; Ye Y; Jhala N; Murphy MP; Kalyanaraman B; Darley-Usmar VM
Hepatology; 2011 Jul; 54(1):153-63. PubMed ID: 21520201
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion
Gan L; Wang Z; Si J; Zhou R; Sun C; Liu Y; Ye Y; Zhang Y; Liu Z; Zhang H
Toxicol Appl Pharmacol; 2018 Feb; 341():1-7. PubMed ID: 29317239
[TBL] [Abstract][Full Text] [Related]
8. The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model.
Dare AJ; Logan A; Prime TA; Rogatti S; Goddard M; Bolton EM; Bradley JA; Pettigrew GJ; Murphy MP; Saeb-Parsy K
J Heart Lung Transplant; 2015 Nov; 34(11):1471-80. PubMed ID: 26140808
[TBL] [Abstract][Full Text] [Related]
9. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α.
Xi Y; Feng D; Tao K; Wang R; Shi Y; Qin H; Murphy MP; Yang Q; Zhao G
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2859-2870. PubMed ID: 29842922
[TBL] [Abstract][Full Text] [Related]
10. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Mao P; Manczak M; Shirendeb UP; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
[TBL] [Abstract][Full Text] [Related]
11. MitoQ protects against liver injury induced by severe burn plus delayed resuscitation by suppressing the mtDNA-NLRP3 axis.
Wu Y; Hao C; Liu X; Han G; Yin J; Zou Z; Zhou J; Xu C
Int Immunopharmacol; 2020 Mar; 80():106189. PubMed ID: 31931374
[TBL] [Abstract][Full Text] [Related]
12. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis.
Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z
J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.
Gazdic M; Simovic Markovic B; Vucicevic L; Nikolic T; Djonov V; Arsenijevic N; Trajkovic V; Lukic ML; Volarevic V
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1173-e1185. PubMed ID: 28488390
[TBL] [Abstract][Full Text] [Related]
14. Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice.
Al Dulaimi D; Klibi J; Olivo Pimentel V; Parietti V; Allez M; Toubert A; Benlagha K
Front Immunol; 2018; 9():1052. PubMed ID: 29868013
[TBL] [Abstract][Full Text] [Related]
15. Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice.
Chen J; Duan L; Xiong A; Zhang H; Zheng F; Tan Z; Gong F; Fang M
J Mol Med (Berl); 2012 Dec; 90(12):1505-15. PubMed ID: 22983503
[TBL] [Abstract][Full Text] [Related]
16. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
[TBL] [Abstract][Full Text] [Related]
17. CD1d-restricted IFN-γ-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1α production and activation of macrophages and dendritic cells.
Kim JH; Chung DH
J Immunol; 2011 Feb; 186(3):1432-41. PubMed ID: 21191075
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.
Gioscia-Ryan RA; LaRocca TJ; Sindler AL; Zigler MC; Murphy MP; Seals DR
J Physiol; 2014 Jun; 592(12):2549-61. PubMed ID: 24665093
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
Li B; Sun R; Wei H; Gao B; Tian Z
Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
[TBL] [Abstract][Full Text] [Related]
20. Betulin from Hedyotis hedyotidea ameliorates concanavalin A-induced and T cell-mediated autoimmune hepatitis in mice.
Zhou YQ; Weng XF; Dou R; Tan XS; Zhang TT; Fang JB; Wu XW
Acta Pharmacol Sin; 2017 Feb; 38(2):201-210. PubMed ID: 27796295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]